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Multiple myeloma is a malignant tumour characterized by proliferation of a single clone of
plasma cells, this cell line will produce large amount of ineffective immunoglobulins that
are ineffective at fighting infection resulting in immunosuppression.
These are medullary tumours most of the time; however, in rare cases they may arise
extra medullary.
The incidence of extramedullary plasmocytoma is about 5% and they arise in the chest
most of the time; but they can also arise in other body systems like gastrointestinal system,
which is involved in 10% of the time. We present a very rare case of primary plasmocytoma
involving the pancreas. According to our research, there are only 25 cases of primary
pancreatic plasmocytoma reported in english literature.
Copyright © 2015, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Extramedullary plasmocytoma is a rare entity. It is usually
diagnosed in patients with widespread multiple myeloma. Its
primary form is extremely rare, and the upper respiratory
tract is the most commonly involved site, with only 10%
involving the gastrointestinal tract. Pancreatic involvement
with plasmocytoma is extremely rare; there are only 25 cases
reported in English literature until 2012 [1].1. Case report
A 66-year-old male patient presented with epigastric pain,
vomiting, and weight loss over a period of several months.
Initial ultrasonographic examination of the upper abdomentify that, to the best of the
pharmaceutical compan
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ND license (http://creativrevealed diffuse intrahepatic and extrahepatic bile duct dila-
tation with no intraductal stone (see Fig. 1). The pancreas was
enlarged, with heterogeneous texture and no pancreatic duct
dilatation. A large hypoechoic mass was identified in the re-
gion of pancreatic head (see Fig. 2) with the vessel piercing the
lesion. The gall bladder wall was thick and edematous (see
Fig. 3).
Subsequent computed tomography (CT) confirmed the
pancreatic head mass had extended into porta hepatis
causing dilatation of biliary ducts with gall bladder neck in-
vasion (see Figs. 4 and 5).
CT images also demonstrated encasement of the celiac
axis and superior mesenteric arteries without occlusion.
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Fig. 3 e Transverse ultrasound (A) and enhanced axial CT
(B) images through the gall bladder show thickened walls
(arrow). SAG GB ¼ sagittal gallbladder.
Fig. 1 e Transverse ultrasound image shows dilated
common bile duct with thickened walls (arrow). CBD ¼
common bile duct.
R a d i o l o g y C a s e R e p o r t s 1 0 ( 2 0 1 5 ) 8 1e8 782The differential diagnosis at this point would possibly
include
1. lymphoma, given the homogeneous nature of the mass
and encasement of the mesenteric blood vessels;
2. pancreatic adenocarcinoma;
3. or, less likely, cholangiocarcinoma.
The patient had a CT-guided biopsy of the pancreaticmass,
which confirmed to be a plasmocytoma (see Fig. 7).
The patient received chemotherapy followed by autolo-
gous bone marrow transplant. Follow-up imaging confirmed
initial good response to treatment, but unfortunately, the
most recent positron emission tomography scan demon-
strated persistent metabolic activity in a lymph nodeFig. 2 e Transverse ultrasound image through the head
and uncinate process of the pancreas shows large
hypoechoic mass (arrow). TRV PANC AREA ¼ transverse
pancreatic area.anterior to the pancreas and in the wall of gall bladder (see
Figs. 8-10).2. Discussion
Multiple myeloma is malignant proliferation of single clone
of plasma celleproducing monoclonal antibodies. Plasmo-
cytoma is a discrete mass of plasma cells, most often in the
bones or occasionally in an extramedullary location [2]. The
latter is rare [3], with median age of presentation at 55
years and a slight male predominance. Plasmocytoma can
be primary or secondary, with the secondary form more
common [2]. Only 5% of plasmocytomas involve extraoss-
eous tissue, and they are typically diagnosed after the
diagnosis of multiple myeloma had been established. Most
of these involve the upper respiratory tract; only 10% in-
volves gastrointestinal tract, mainly the stomach, the liver,
and the spleen. There are only 25 cases of pancreatic
Fig. 6 e Axial CT images in bone window shows
widespread lytic bony lesions (arrows). A, at the level of
middle thoracic spine. B, at the level of sacrum.
Fig. 4 e Transverse ultrasound (A) and enhanced axial CT
(B) images show dilated intrahepatic biliary tree (arrow).
TRV RT LIVER ¼ transverse right liver.
Fig. 5 e Enhanced axial CT image through the pancreatic
mass at the portal venous phase demonstrated diffuse
homogeneous enhancement.
Fig. 7 e CT-guided biopsy of the pancreatic mass using
18-gauge quick core needle biopsy in the prone position.
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Fig. 8 e A shows the extent of soft tissue involvement, B and C demonstrate the extent of bony involvement. Positron
emission tomography scan before chemotherapy demonstrates the extent of the disease (arrows).
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Fig. 9 e Positron emission tomography scan after chemotherapy demonstrates a response manifested by decrease in the
pancreatic mass with persistent activity in the gall bladder (A and B).
R a d i o l o g y C a s e R e p o r t s 1 0 ( 2 0 1 5 ) 8 1e8 7 85involvement in the English literature [1]. A pancreatic mass
in a patient with an established diagnosis of multiple
myeloma should raise the suspicion of pancreatic involve-
ment by the disease [4].
It can involve any part of the pancreas. Pancreatic head
involvement is by far the most common [2], resulting in upper
abdominal pain and obstructive jaundice.
The radiologic findings of pancreatic plasmocytoma are not
very specific. Ultrasonography demonstrates a heterogeneousmass that is hypoechoic to the surrounding tissue. CT shows
homogeneous enhancement of amultilobulatedmass. Diffuse
pancreatic enlargement isoftendescribed.Dual-phaseCTwith
pancreatic protocol is considered the modality of choice
allowing assessment of vascularity. Magnetic resonance im-
aging is felt less favored currently [5]. Although CT scan is the
investigation of choice, imaging features are not specific and
may mimic other entities such as pancreatic carcinoma, lym-
phoma, islets cell tumor, and metastasis [6].
Fig. 10 e Positron emission tomography scan after bone marrow transplant demonstrates a significant decrease in the
pancreatic mass size with some persistent activity in a small node anterior to the pancreas and the wall of gall bladder
(A and B).
R a d i o l o g y C a s e R e p o r t s 1 0 ( 2 0 1 5 ) 8 1e8 786The treatment of multiple myeloma includes steroid
and chemotherapy in addition to radiation therapy for symp-
tomatic lesions. Other methods of treatment are under inves-
tigation such as thalidomide, angiogenic agents, and stem cell
transplant. To our knowledge, there is no standardized treat-
ment targeting extramedullary plasmocytoma [5].3. Conclusion
Pancreatic plasmocytoma is a rare entity; it should be consid-
ered in the differential diagnosis in patients presenting with a
hypoechoicpancreaticheadmassanddiffuse lytic bony lesions.
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